Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:40:48.194Z.
Consensus retrieved: 2026-10-06T08:46:20.055Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:40:48.194Z.
Quote observation: 2026-10-06T15:40:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a397cd850420951a0c9724a6b76f21fabdb26d17d869f1b33831b183cdf643d3
Forward PE Ratio (N/A) = Dated Quote Price ($3.57) / Consensus Forward EPS ($-22.68)
FORWARD PE RATIO
N/A
Autonomix Medical, Inc.
Market Cap
$1.94M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Autonomix Medical, Inc. (AMIX) | $1.94M | N/A |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.81M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.33M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.33M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | N/A |
| Curis, Inc. (CRIS)vs › | $1.47M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.46M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.48M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-03-31
At the dated quote price of $3.57, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $-22.68 | $-22.68 – $-22.68 | 1 | n/m |
| 2028-03-31 | $-19.53 | $-19.53 – $-19.53 | 1 | n/m |
| 2029-03-31 | $-17.43 | $-17.43 – $-17.43 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
